OTHER · Unmapped registry intervention
Symptom Assessment Scale
Find medicine records ·
Find other trials using this name
Clinical trial
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
NCT00608452
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPrevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Ovarian Cancerverified · MONDO: ovarian cancer
Breast Cancerverified · MONDO: breast cancer
Hodgkin's Diseaseverified · MONDO: Hodgkins lymphoma
Neuroblastomaverified · MONDO: neuroblastoma
Interventions
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00608452 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.